TELVAS H TAB

About Telmisartan/Hydrochlorothiazide, known as Telvas H, is a combination medication indicated for the treatment of essential hypertension. Telmisartan is an angiotensin II receptor blocker (ARB) that works by selectively blocking the effects of angiotensin II, a potent vasoconstrictor. This action leads to vasodilation and reduced blood pressure. Hydrochlorothiazide (HCTZ) is a thiazide diuretic that increases the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubule of the kidney. The combination provides additive antihypertensive effects, as the diuretic action of HCTZ complements the vasodilatory and volume-reducing effects of telmisartan. This often leads to more effective blood pressure control than either agent alone and can help mitigate the potassium loss sometimes associated with HCTZ monotherapy, offering a balanced approach to hypertension management. Uses Treatment of essential hypertension. When monotherapy with telmisartan or HCTZ is insufficient. To achieve optimal blood pressure control. To reduce the risk of cardiovascular events in hypertensive patients. Directions For Use Take orally once daily, with or without food, as directed by your healthcare provider. Swallow the tablet whole. Benefits Provides effective and sustained blood pressure reduction. Combines two complementary antihypertensive mechanisms. Offers convenient once-daily dosing. Reduces the risk of cardiovascular morbidity and mortality. Helps manage fluid retention in hypertensive patients. May mitigate potassium loss compared to HCTZ alone. Side Effects Dizziness Headache Fatigue Hypotension (low blood pressure) Hypokalemia (low potassium, less common than HCTZ alone) Hyponatremia (low sodium) Hyperuricemia (high uric acid) Muscle cramps Nausea Diarrhea Cough (less common than with ACE inhibitors) Renal impairment (rare) Safety Measures Alcohol - Alcohol can potentiate the hypotensive effects; use with caution and avoid excessive intake. Pregnancy - Contraindicated in pregnancy due to potential fetal harm from telmisartan (renal dysfunction, oligohydramnios). Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and harm the infant. Liver - Use with caution in hepatic impairment; dose adjustment may be necessary, especially with severe impairment. Kidney - Contraindicated in anuria; use with caution in severe renal impairment, monitor kidney function and electrolytes. Lung - Generally safe for use in patients with lung conditions; however, HCTZ can rarely cause acute pulmonary edema. Disclaimer MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment. Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub. Our goal is to complement, not replace, the essential doctor-patient relationship.